Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Heart Journal

• Publication date

  2016-07-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehw301PMID 27436865PMCID PMC5837662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.

  2016cited by this paper
• Demographic and epidemiologic drivers of global cardiovascular mortality.

  2015cited by this paper
• An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.

  2015cited by this paper
• 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.

  2014cited by this paper
• Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

  2014cited by this paper
• Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

  2014cited by this paper
• Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012.

  2014cited by this paper
• Statins: new American guidelines for prevention of cardiovascular disease.

  2013cited by this paper
• Multiple imputation using chained equations: Issues and guidance for practice

  2011cited by this paper
• Overview of Race and Hispanic Origin: 2010

  2011cited by this paper
• A simple approach to the estimation of incidence rate difference.

  2010cited by this paper
• Linear versus logistic regression when the dependent variable is a dichotomy

  2009cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

  2008cited by this paper
• Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

  2007cited by this paper
• Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004

  2007cited by this paper
• Relative Risk Regression in Medical Research: Models, Contrasts, Estimators, and Algorithms

  2006cited by this paper
• Adherence to a Mediterranean diet and survival in a Greek population.

  2003cited by this paper
• Multi-Ethnic Study of Atherosclerosis: objectives and design.

  2002cited by this paper
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

  1993cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

  1989cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

  1989cited by this paper
• CARDIA: study design, recruitment, and some characteristics of the examined subjects.

  1988cited by this paper

• Socioeconomic and Engagement Barriers to Cardiovascular Risk Awareness Among Cancer Survivors

  2026cites this paper
• Relationship Between Metabolic Age Determined by Bioimpedance and Insulin Resistance Risk Scales in Spanish Workers

  2025cites this paper
• Cardiovascular risk stratification without recalibration: A comparative study of the PREVENT and WHO risk scores in a multiethnic Brazilian cohort

  2025cites this paper
• Cardiovascular disease risk estimates using the new PREVENT Equation: The good, bad, and the ugly

  2025cites this paper
• Assessing cardiovascular disease risk and social determinants of health: A comparative analysis of five risk estimation instruments using data from the Eastern Caribbean Health Outcomes Research Network

  2025cites this paper
• Updates on CAD risk assessment: using the coronary artery calcium score in combination with traditional risk factors

  2025cites this paper
• Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older

  2025cites this paper
• Differences in Statin Eligibility with the Use of Predicting Risk of Cardiovascular Disease EVENTs Versus Pooled Cohort Equations in the UK Biobank.

  2025cites this paper
• Severe-Extensive Coronary Atherosclerosis in Low-Risk Individuals and Absence of Coronary Atherosclerosis in High-Risk Individuals: The SCAPIS Extremes Project.

  2025cites this paper
• Atherosclerotic Cardiovascular Disease Risk Estimates Using the New Predicting Risk of Cardiovascular Disease Events Equations: Implications for Statin Use

  2025cites this paper
• A nomogram model in elderly patients with coronary heart disease for predicting prognosis: research based on a real-world registry in China

  2025cites this paper
• Relationship between 10- and 30-year PREVENT Risk Scores with Coronary Artery Calcium and Incident Atherosclerotic Cardiovascular Disease: MESA.

  2025cites this paper
• Coronary artery calcium burden across the pooled cohort equation versus the American Heart Association PREVENT risk calculator

  2025cites this paper
• Meta-prediction of coronary artery disease risk

  2025cites this paper
• Sex differences in the applicability of Western cardiovascular disease risk prediction equations in the Asian population

  2024cites this paper
• Major Limitations of Cardiovascular Risk Scores

  2024cites this paper
• Structural and social determinants of health: The multi-ethnic study of atherosclerosis

  2024cites this paper
• Correlation of Plasma Fibroblast Growth Factor 23 with the Risk of Cardiovascular Disease in a Group of Iraqi Patients with Type 2 Diabetes Mellitus

  2024cites this paper
• Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.

  2024cites this paper
• Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease

  2024cites this paper
• Coronary artery calcification score and 19 biomarkers on cardiovascular events; a 10-year follow-up DanRisk substudy

  2024cites this paper
• 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.

  2024cites this paper
• Addition of Social Determinants of Health to Coronary Heart Disease Risk Prediction: The Multi‐Ethnic Study of Atherosclerosis

  2024cites this paper
• Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohorts

  2024cites this paper
• Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study

  2024cites this paper
• Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations.

  2024cites this paper
• The Acute Coronary Syndrome Risk in Medically Managed Subjects with Type 2 Diabetes Mellitus – Is the ASCVD Risk Score Failing Here?

  2024cites this paper
• Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older

  2024cites this paper
• The art of deciphering and communicating cardiovascular risk: getting it right.

  2024cites this paper
• Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population

  2023cites this paper
• Meta-Prediction of Coronary Artery Disease Risk

  2023cites this paper
• Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines

  2023cites this paper
• Utility of coronary artery calcium in refining 10-year ASCVD risk prediction using a Thai CV risk score

  2023cites this paper
• EXIST: EXamining rIsk of excesS adiposiTy—Machine learning to predict obesity‐related complications

  2023cites this paper
• Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosifs.

  2023cites this paper
• Biomarker guided management of hypertension

  2023cites this paper
• Risk Stratification of Cardiovascular Disease according to Age Groups in New Prevention Guidelines: A Review

  2023cites this paper
• Artificial intelligence in cardiovascular prevention: new ways will open new doors

  2023cites this paper
• Comparison of ct angiography and scoring systems for cardiovascular risk stratification in asymptomatic patients

  2023cites this paper
• 2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.

  2023cites this paper
• Net benefit, calibration, threshold selection, and training objectives for algorithmic fairness in healthcare

  2022cites this paper
• Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China

  2022cites this paper
• Predictive values of coronary artery calcium and arterial stiffness for long‐term cardiovascular events in patients with stable coronary artery disease

  2022cites this paper
• Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach

  2022cites this paper
• Prognostic Value of Ankle-Brachial Index in Prediction of Cardiovascular Events in an Asian Population with Multiple Atherosclerotic Risk Factors

  2022cites this paper
• Cardiovascular disease risk prediction models in the Chinese population- a systematic review and meta-analysis

  2022cites this paper
• The Impact of Time Horizon on Classification Accuracy: Application of Machine Learning to Prediction of Incident Coronary Heart Disease

  2022cites this paper
• Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues

  2022cites this paper
• Prediction performance and fairness heterogeneity in cardiovascular risk models

  2022cites this paper
• Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine

  2022cites this paper
• A Review of National Level Guidelines for Risk Management of Cardiovascular and Diabetic Disease

  2022cites this paper
• Guidelines for the Prevention of Symptomatic Cardiovascular Disease, Based upon the Presence of Coronary Artery Calcified Plaque—Provided by the Society for the Prevention of Symptomatic Heart Disease

  2022cites this paper
• 2022 Taiwan lipid guidelines for primary prevention.

  2022cites this paper
• 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.

  2022cites this paper
• Integrated approach of brachial-ankle pulse wave velocity and cardiovascular risk scores for predicting the risk of cardiovascular events

  2022cites this paper
• Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database

  2022influential citation
• Coronary Risk Estimation Based on Clinical Data in Electronic Health Records.

  2022cites this paper
• Artificial Intelligence Advancements in the Cardiovascular Imaging of Coronary Atherosclerosis

  2022cites this paper
• Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

  2022cites this paper
• Gauging ASCVD Risk, Does Race Matter?

  2022cites this paper
• Further understanding of ideal cardiovascular health score metrics and cardiovascular disease

  2021cites this paper
• Carotid artery molecular calcification assessed by [18F]fluoride PET/CT: correlation with cardiovascular and thromboembolic risk factors

  2021cites this paper
• 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

  2021cites this paper
• Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies

  2021cites this paper
• Characterizing and Quantifying Performance Heterogeneity in Cardiovascular Risk Prediction Models — A Step Towards Improved Disease Risk Assessment

  2021cites this paper
• Challenges in Optimizing Lipid Management in Women

  2021cites this paper
• Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease

  2021cites this paper
• Population Screening With Coronary Computed Tomography Angiography and the Prevention of Coronary Events.

  2021cites this paper
• Development of a Korean-specific cardiovascular risk model in a cohort at high-risk of hypertension

  2021cites this paper
• Fitness and Mortality Among Persons 70 Years and Older Across the Spectrum of Cardiovascular Disease Risk Factor Burden: The FIT Project.

  2021cites this paper
• Pooled Cohort Equations and the competing risk of cardiovascular disease versus cancer: Multi-Ethnic study of atherosclerosis

  2021cites this paper
• Cardiovascular Risk Based on ASCVD and KDIGO Categories in Chinese Adults: A Nationwide, Population-Based, Prospective Cohort Study.

  2021cites this paper
• Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts

  2021cites this paper
• Prevention of Cardiovascular Disease

  2021cites this paper
• Performance of the Pooled Cohort Equations in Hispanic Individuals Across the United States: Insights From the Multi‐Ethnic Study of Atherosclerosis and the Dallas Heart Study

  2021cites this paper
• Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease

  2021cites this paper
• Dietary intake of total, animal and plant proteins and the risk of coronary heart disease and hypertension: a systematic review and dose-response meta-analysis of prospective cohort studies

  2020cites this paper
• Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people.

  2020cites this paper
• Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort

  2020influential citation
• Association between Blood Heavy Metal Levels and Predicted 10-Year Risk for A First Atherosclerosis Cardiovascular Disease in the General Korean Population

  2020cites this paper
• The year 2019 in Atherosclerosis.

  2020cites this paper
• Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries

  2020cites this paper
• Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations

  2020cites this paper
• Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study

  2020cites this paper
• Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention

  2020cites this paper
• Prevalence, Awareness, Treatment, and Poor Control of Hypertension Among Young American Adults: Race-Stratified Analysis of the National Health and Nutrition Examination Survey.

  2020cites this paper
• The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach

  2020cites this paper
• Optimizing Atherosclerotic Cardiovascular Disease Risk Estimation for Veterans With Diabetes Mellitus

  2020cites this paper
• Relation of Absence of Coronary Artery Calcium to Cardiovascular Disease Mortality Risk among Individuals Meeting Criteria for Statin Therapy According to the 2018/2019 ACC/AHA Guidelines.

  2020cites this paper
• Metabolic age correlates better than chronological age with waist-to-height ratio, a cardiovascular risk index.

  2020cites this paper
• Estimation of 10-Year Risk of Death from Coronary Heart Disease, Stroke, and Cardiovascular Disease in a Pooled Analysis of Japanese Cohorts: EPOCH-JAPAN

  2020cites this paper
• Interaction between predisposing genes and environmental risk factors in cardiovascular disease: how prevention can counteract this salty combination.

  2020cites this paper
• Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths.

  2020cites this paper
• 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021.

  2020cites this paper
• Risk Models and Scores of Cardiovascular Disease in Patients with Diabetes Mellitus.

  2020cites this paper
• American, European and international hypertension guidelines: Time to shake hands?

  2020cites this paper
• Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors

  2020cites this paper
• The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: A Personalized Approach to Risk Reduction

  2020cites this paper
• факторов риска, течения инфаркта миокарда и тактики ведения пациентов молодого по двух госпитальных регистров

  2020cites this paper
• 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report the Task Force on Performance Measures

  2020cites this paper